EP2425250

METHODS FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    27.4.2010
  • :
    26.2.2014
  • :
    10716450.1
  • :
    26.4.2030
  • :
    METHODS FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS

27.4.2010
26.2.2014
  • :
    AbbVie Biotherapeutics Inc.
  • :
    1500 Seaport Boulevard, 94063, Redwood City, CA, US
  • :
    SHERIDAN III, James Peter
  • :
    Mountain ViewCalifornia, US
  • :
    173138 P
  • :
    27.4.2009
  • :
    US
  • :
    WO2010126890
  • :
    27.4.2010
  • :
    G01N 33/50, G01N 33/564